Screening of Nutritional Status in Cardiac Surgery

Completed

• Conditions: Cardiovascular Diseases

• Registration Number: NCT01366807
• Lead Sponsor: Meshalkin Research Institute of Pathology of Circulation

Brief Summary

Screening of nutritional status is unsolved problem in cardiac surgery. Applicability of such criteria as body mass index and albumin and screening scales (MNA, NRS-2002, SGA, SNAQ) in cardiac surgery is controversial and insufficiently studied. Furthermore, there is some known predictors of poor outcome, which closely related to nutritional status (C-reactive protein, total lymphocyte count). The aim of this study is assessment of several nutritional screening scales, objective nutritional criteria and predictors for the purpose of detection of most informative one or its combination.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-01
• Study First Submitted: 2011-05-31
• Study First Submitted QC: 2011-06-03
• Study First Posted: 2011-06-06
• Primary Completion: 2013-10
• Study Completion: 2013-10
• Status Verified: 2020-01
• Last Update Submitted: 2020-01-16
• Last Update Posted: 2020-01-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1210

Inclusion Criteria

• Adult patients with cardiovascular disease operated on under cardiopulmonary bypass

Exclusion Criteria

• Age under 18 years
• Emergency
• Participation in other trial.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mortality	Participants will be followed for the duration of hospital stay, an average of 4 weeks.

Secondary Outcome Measures

Name	Time	Method
Intensive care unit stay	Participants will be followed for the duration of hospital stay, an average of 4 weeks.
Ventilation time	Participants will be followed for the duration of hospital stay, an average of 4 weeks.	Period between admission to ICU after the surgery and extubation
Complications	Participants will be followed for the duration of hospital stay, an average of 4 weeks.	Postoperative cardiac failure, infectious complications, clinically significant arrhythmia, bleeding
Hospital stay	Participants will be followed for the duration of hospital stay, an average of 4 weeks.

Trial Locations

Locations (1)

Novosibirsk Research Institute of Patholgy of Circulation; 🇷🇺 Novosibirsk, Russian Federation